Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Oxford BioMedica starts second CART programme for undisclosed indication Oxford BioMedica has initiated work on a second Chimeric Antigen Receptor T cell (CART) programme for an undisclosed indication.
Production & Manufacturing > Manufacturing > News
Shire acquires Dyax for $5.9bn Irish-headquartered Shire has acquired the US-based biopharmaceutical firm Dyax for about $5.9bn.
Production & Manufacturing > Manufacturing > News Asterias transfers AST-VAC2 manufacturing process to Cancer Research UK Asterias Biotherapeutics has completed the transfer of its manufacturing processes to produce AST-VAC2 to Cancer Research UK.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Elemental Impurity Analysis in Pharmaceuticals – The Road To Implementation of ICH Q3D
| By Butterworth Laboratories Ltd
Elemental impurities have been a hot topic since 2009 when the International Conference of Harmonisation (ICH) commenced work on a new standard to provide a global policy to limit these impurities in drug products and ingredients. Their guidance document, Q3D, reached step 4 in December 2014, meaning the final draft is recommended for adoption to the regulatory bodies of the European Union, Switzerland, Japan, USA and Canada.
Production & Manufacturing > Manufacturing > White Papers
Asterias transfers AST-VAC2 manufacturing process to Cancer Research UK
Asterias Biotherapeutics has completed the transfer of its manufacturing processes to produce AST-VAC2 to Cancer Research UK.
Production & Manufacturing > Manufacturing > News
Drug companies urge governments to join fight on superbugs
By PBR Staff Writer
Drug manufacturers from across the world called for governments and industry to join forces in combating superbugs, which are strains of bacteria that are resistant to various antibiotic types.
Production & Manufacturing > Manufacturing > News
Cellectis inks deal with CELLforCURE for cGMP manufacturing of UCART123
Cellectis has signed agreement with CELLforCURE for the cGMP manufacturing of UCART123 clinical batches for hematological malignancies.
Production & Manufacturing > Manufacturing > News
Blending Solutions for Food and Pharma
Scott Heffern: Our wheelhouse and blending is IBC blending, containment blending, many different words for it. We make many different types of blenders. We make V-blenders, double cone blenders, kind of the old standards, check blenders.
Production & Manufacturing > Manufacturing > Press Releases
GlobalData says Shire's acquisition of Baxalta marks strong start to healthcare mergers and acquisitions for 2016
With Shire's acquisition of Baxalta International expected to generate sales of $20bn by 2020, the deal marks a strong start to healthcare Mergers and Acquisitions (M&A) for 2016, following on from a record-breaking year in which global transactions totaled $680bn in 2015, according to research and consulting firm GlobalData.
Production & Manufacturing > Manufacturing > News
Oxford BioMedica wins UK MHRA approval to manufacture bulk drug material at Yarnton plant
Oxford BioMedica has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for Investigational Medicinal Products (IMPs) at the Group’s recently established and commissioned specialist biomanufacturing facility in Yarnton, Oxford, UK.
Production & Manufacturing > Manufacturing > News
Shire and Baxalta agree on $32bn merger
By PBR Staff Writer
Irish drugmaker Shire has agreed to merge with American biopharmaceutical firm Baxalta under a transaction worth about $32bn.
Production & Manufacturing > Manufacturing > News
Integrating Systems
Bob Luebbe: Many years ago a system was one or two pieces of equipment put together. What we do now are really bring a whole lot of different pieces together. It used to be just a bin and a blender or a bin and a discharge station, a bin and a fill station. Now it's filling, it's blending, it's discharging, its containment.
Production & Manufacturing > Manufacturing > Press Releases
Agenus acquires PhosImmune with novel class of cancer neoantigens
Agenus has acquired PhosImmune, a company that has discovered an entirely new portfolio of cancer neoantigens.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests